Transcera
Boston, US · 3 known investors
Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases. Its platform combines a lysosome-targeting lipid, a chemical linker, and a peptide or protein binder to degrade soluble and membrane proteins across tissues.
BiotechDeep Tech
Founders & leadership
WL
Wayne LencerCo-Founder & SAB Chair
HG
Hunter GobleCo-Founder & CEO
JW
Justin WolfeCo-Founder & CSO
Investors · 3
Frequently asked questions
- What does Transcera do?
- Transcera is a biotech company developing a new class of therapeutics that use lipid trafficking pathways to direct extracellular proteins into lysosomes for degradation, aimed at treating chronic diseases. Its platform combines a lysosome-targeting lipid, a chemical linker, and a peptide or protein binder to degrade soluble and membrane proteins across tissues.
- Who founded Transcera?
- Transcera was founded by Wayne Lencer, Hunter Goble, Justin Wolfe.
- Who are Transcera's investors?
- Transcera's investors include Portal Innovations, Tau Ventures, KdT Ventures.
- Where is Transcera headquartered?
- Transcera is headquartered in Boston, US.